\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Stock Quote

NASDAQCRDF
$21.92
NASDAQCRDF
Open
$21.33
Change
$0.61 (2.86%)
Day's Range
$21.00 - $22.68
52-Week Range
$0.71 - $22.69
Volume
665.5K
Market Cap
$774.3M